U.S. FDA approves GSK's three-in-one drug inhaler for COPD

(Reuters) - GlaxoSmithKline Plc and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for treatment of chronic obstructive pulmonary disease (COPD).